Immediate Impact

3 by Nobel laureates 2 from Science/Nature 57 standout
Sub-graph 1 of 22

Citing Papers

The present and future of bispecific antibodies for cancer therapy
2024 Standout
Renal cell carcinoma
2024 Standout
3 intermediate papers

Works of Kolette D. Fly being referenced

First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin Lymphomas
2020
Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
2013
and 1 more

Author Peers

Author Last Decade Papers Cites
Kolette D. Fly 175 230 117 15 449
Byung Woog Kang 240 192 106 21 402
Su Y. Kim 85 95 82 11 378
Christopher Riley 175 116 70 11 507
Jan Åhlén 106 164 84 20 389
H Wang 183 95 77 16 481
Ulla Vanleeuw 132 222 157 22 384
Jong Ho Chun 202 195 38 21 411
Jasmien Wellens 142 290 207 28 458
Gwendoline Soler 150 200 19 14 409
J. Mazurka 119 85 29 15 484

All Works

Loading papers...

Rankless by CCL
2026